Cholesterol and Body Composition: What Your DEXA Scan Reveals About Cardiovascular Lipid Risk

Most people think of cholesterol as a blood test result, a set of numbers on a lab report that either passes or fails. But cholesterol levels do not exist in isolation. They are shaped, in large part, by what is happening inside your body at a tissue level, specifically by how much fat you carry, where that fat sits, and how metabolically active it is.

A growing body of peer-reviewed research confirms that body fat distribution is a stronger predictor of dyslipidaemia (abnormal cholesterol) than total body weight or BMI. Two people with the same BMI can have vastly different cholesterol profiles depending on their ratio of visceral to subcutaneous fat, their lean muscle mass, and the way fat is distributed between their trunk and limbs.

This is where a DEXA scan becomes valuable. By measuring visceral adipose tissue, regional fat distribution, and the android-to-gynoid fat ratio, a DEXA scan provides data that directly correlates with the lipid markers your GP checks in a standard blood panel. Understanding that connection puts you in a stronger position to manage your cardiovascular health proactively.

Cholesterol is a waxy substance your body needs to build cells, produce hormones, and manufacture vitamin D. Your liver produces most of the cholesterol in your blood, but dietary intake also plays a role. Cholesterol travels through the bloodstream attached to proteins called lipoproteins, and it is the balance between these lipoproteins that determines your cardiovascular risk.

There are two main types to understand. Low-density lipoprotein (LDL) carries cholesterol to your arteries, where excess amounts can accumulate as plaque and narrow the vessels. High-density lipoprotein (HDL) carries cholesterol away from the arteries and back to the liver for disposal. Triglycerides, a third lipid marker, represent the most common type of fat stored in your body and are closely tied to diet, alcohol intake, and metabolic function.

According to NHS guidelines, a healthy total cholesterol level should be 5.0 mmol/L or below. Non-HDL cholesterol (sometimes called “bad” cholesterol) should be under 4.0 mmol/L. HDL cholesterol should be above 1.0 mmol/L for men and 1.2 mmol/L for women. Triglycerides should sit below 2.3 mmol/L on a non-fasting test.

When these numbers fall outside healthy ranges, the condition is called dyslipidaemia. It is one of the strongest modifiable risk factors for coronary heart disease and stroke, and it often occurs without any noticeable symptoms, which is why proactive monitoring matters.

Not all body fat behaves the same way. Subcutaneous fat, the layer you can pinch beneath your skin, is relatively inert from a metabolic standpoint. It stores energy and provides insulation, but it does not significantly disrupt your lipid profile. Visceral fat, however, is a different matter entirely.

Visceral adipose tissue (VAT) sits deep inside the abdominal cavity, surrounding your liver, pancreas, intestines, and kidneys. Unlike subcutaneous fat, visceral fat is metabolically active. It releases free fatty acids directly into the portal vein, which carries blood to the liver. This flood of fatty acids stimulates the liver to produce more LDL cholesterol and triglycerides while simultaneously reducing the production of HDL cholesterol.

A dual-energy computed tomography study published in Cureus (2024) confirmed that total visceral fat area positively correlates with total cholesterol, LDL cholesterol, and triglycerides, while an inverse relationship exists between visceral fat volume and HDL cholesterol. Critically, this correlation held even after adjusting for age, gender, and BMI, confirming that visceral fat is an independent predictor of lipid abnormalities.

This means two people with the same body weight can have fundamentally different cholesterol profiles. Someone with a healthy BMI but elevated visceral fat (a pattern known as normal weight obesity) may have worse cholesterol numbers than someone who weighs more but carries their fat subcutaneously.

The mechanisms connecting visceral fat to dyslipidaemia are well established in the medical literature. Understanding them helps explain why reducing visceral fat specifically, rather than simply losing weight, is the most effective strategy for improving your lipid profile.

Free fatty acid release. Visceral adipocytes (fat cells) are more lipolytically active than subcutaneous fat cells, meaning they break down stored triglycerides and release free fatty acids at a higher rate. These fatty acids travel directly to the liver via the portal vein, where they serve as raw material for producing very-low-density lipoprotein (VLDL) particles. VLDL is the precursor to LDL cholesterol, so more visceral fat means more LDL in circulation.

Chronic low-grade inflammation. Visceral fat secretes pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha). These inflammatory signals interfere with the liver’s ability to clear LDL particles from the bloodstream and reduce the production of apolipoprotein A-I, the primary protein component of HDL cholesterol. The result is both higher LDL and lower HDL.

Insulin resistance. Excess visceral fat promotes insulin resistance, which disrupts the normal regulation of lipid metabolism. When cells become resistant to insulin, the liver overproduces triglyceride-rich particles, and the clearance of triglycerides from the blood slows down. This creates the characteristic pattern of high triglycerides and low HDL that clinicians call atherogenic dyslipidaemia, one of the strongest predictors of cardiovascular events.

Research published in Atherosclerosis found that visceral fat accumulation measured by MRI correlated with serum lipid abnormalities independently of total body fat, reinforcing the clinical importance of measuring where fat sits, not just how much of it you carry.

A DEXA (dual-energy X-ray absorptiometry) scan provides several measurements that relate directly to your cholesterol and cardiovascular risk profile.

Visceral adipose tissue (VAT). DEXA quantifies the mass of visceral fat in your abdominal region. A visceral adipose tissue area greater than 100 cm² is widely recognised as a threshold indicating elevated cardiovascular and metabolic risk, including dyslipidaemia. Your DEXA report shows exactly where you fall relative to this threshold.

Android-to-gynoid fat ratio (A/G ratio). The android region refers to fat stored around your waist and abdomen, while the gynoid region refers to fat stored around your hips and thighs. An A/G ratio above 1.0 is associated with increased metabolic and cardiovascular disease risk. We explored this metric in detail in our guide to android-to-gynoid fat ratio and heart disease risk. A high A/G ratio consistently tracks with elevated LDL cholesterol and triglycerides, regardless of total body fat percentage.

Total and regional body fat percentage. While total body fat percentage matters, the regional breakdown is often more informative. Two individuals with 30% body fat may have very different cholesterol profiles if one stores fat predominantly in the trunk (android pattern) and the other stores it in the limbs (gynoid pattern).

Lean mass. Higher lean muscle mass is associated with better insulin sensitivity and improved lipid metabolism. Your DEXA scan measures lean mass in each region of your body, providing context that a cholesterol blood test alone cannot offer. People who lose weight through crash dieting often lose lean mass alongside fat, which can paradoxically worsen their metabolic profile even as the number on the scale drops.

The relationship between body fat distribution and cholesterol differs between men and women, and understanding these differences matters for interpreting both your DEXA results and your blood lipid panel.

Research examining visceral fat and serum lipids found that in women, visceral fat accumulation was associated with a less favourable lipid profile even after adjusting for age and total body fat percentage. Specifically, women with higher visceral fat showed elevated triglycerides, lower HDL cholesterol, and a diminished HDL-to-LDL ratio. This association remained statistically significant regardless of how much total fat the women carried.

In men, the picture was more complex. The significant correlations between visceral fat and lipid markers diminished after adjusting for age and total fat percentage, suggesting that in men, overall adiposity and age contribute more heavily to cholesterol abnormalities than visceral fat distribution alone.

These findings have practical implications. For women, even a modest increase in visceral fat can shift cholesterol levels unfavourably, making regular DEXA monitoring particularly valuable during life stages when fat redistribution is common, such as perimenopause and menopause. For men, the relationship between body composition and cholesterol is more tied to total adiposity, meaning that overall fat reduction tends to produce the most significant lipid improvements.

The clinical evidence is clear: reducing visceral fat improves cholesterol levels. A study published in Nutrients (2024) demonstrated that dietary interventions leading to visceral adipose tissue reduction directly correlated with decreases in LDL cholesterol, confirming a causal relationship between visceral fat changes and lipid improvements.

The most effective strategies target visceral fat specifically rather than simply reducing total body weight.

Resistance training. Building lean muscle mass improves insulin sensitivity and enhances lipid metabolism. Muscle tissue is metabolically active and helps regulate cholesterol clearance. A combination of resistance training and moderate cardiovascular exercise has been shown to reduce visceral fat more effectively than cardio alone.

Dietary quality over calorie restriction. Diets rich in polyunsaturated fatty acids (PUFAs) have been shown to preferentially reduce visceral fat and improve LDL cholesterol levels. Severe calorie restriction, by contrast, risks muscle loss, which can worsen metabolic health in the long term. The NICE guidelines recommend limiting total fat intake to 30% or less of total energy, with saturated fat kept below 7%, and replacing saturated fats with unsaturated alternatives where possible.

Adequate protein intake. Sufficient protein supports lean mass preservation during any fat loss programme, which protects against the metabolic deterioration that can accompany rapid weight loss. Preserving muscle while losing visceral fat produces the most favourable changes in cholesterol levels.

Medical weight management. For individuals whose visceral fat remains stubbornly elevated despite lifestyle changes, medically supervised weight management programmes can produce significant improvements. Research consistently shows that even a 5 to 10% reduction in body weight, particularly when that reduction comes from visceral fat, can meaningfully improve LDL, HDL, and triglyceride levels.

Using a DEXA scan to track these changes gives you objective data on whether your interventions are reducing visceral fat specifically, or whether you are losing lean mass instead, which would require a strategy adjustment.

Can a DEXA scan predict my cholesterol levels?

A DEXA scan does not measure cholesterol directly, but it measures visceral fat, android-to-gynoid ratio, and regional fat distribution, all of which are independent predictors of dyslipidaemia. High visceral fat on a DEXA scan strongly correlates with elevated LDL cholesterol and triglycerides and reduced HDL cholesterol. Combining your DEXA results with a standard blood lipid panel gives the most complete picture of your cardiovascular risk.

My BMI is normal but my cholesterol is high. Could body composition be the reason?

Yes. This pattern is common in people with normal weight obesity, where BMI falls within the healthy range but visceral fat is elevated. A DEXA scan can reveal whether you carry excess visceral fat despite a normal BMI, explaining why your cholesterol numbers are higher than expected.

How much visceral fat is too much?

A visceral adipose tissue area greater than 100 cm² is generally considered the threshold for elevated cardiovascular and metabolic risk. Your DEXA scan report will show your visceral fat measurement and how it compares to healthy reference ranges for your age and sex.

Will losing weight automatically improve my cholesterol?

Not necessarily. The type of weight you lose matters. Losing visceral fat improves cholesterol, but losing lean muscle mass (which commonly happens with crash diets) can worsen metabolic health. A DEXA scan before and after a weight management programme confirms whether you are losing the right kind of tissue.

How often should I have a DEXA scan if I am managing high cholesterol?

If you are actively working to improve your body composition and cholesterol levels through diet, exercise, or medical treatment, a follow-up DEXA scan every 3 to 6 months provides enough time for measurable changes to occur. Your clinician can advise on the right interval based on your individual risk profile.

Does exercise type matter for cholesterol improvement?

Yes. Resistance training combined with moderate cardiovascular exercise reduces visceral fat more effectively than either alone. Since visceral fat reduction is the primary driver of cholesterol improvement through body composition changes, a combined programme tends to produce the best lipid outcomes.

If you are concerned about your cholesterol levels, or if your GP has identified dyslipidaemia and you want to understand the body composition factors driving it, a DEXA scan at our Harley Street clinic provides the data you need.

Your scan takes approximately 15 minutes and delivers a detailed report covering visceral adipose tissue volume, android-to-gynoid fat ratio, regional fat distribution, lean mass, and bone density. These measurements, when combined with your blood lipid panel, give you and your clinician a far more complete picture of your cardiovascular risk than either test provides alone.

To book your DEXA body composition scan, call us on 0207 637 8227 or visit our clinic at 86 Harley Street, London. Same-week appointments are typically available.

Reviewed by Dr Emil Gadimali, Clinical Director, DEXA London